Pictet Asset Management Holding Sa Cure Vac N.V. Transaction History
Pictet Asset Management Holding Sa
- $85.6 Billion
- Q2 2024
A detailed history of Pictet Asset Management Holding Sa transactions in Cure Vac N.V. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 95,362 shares of CVAC stock, worth $328,045. This represents 0.0% of its overall portfolio holdings.
Number of Shares
95,362
Previous 12,073
689.88%
Holding current value
$328,045
Previous $36,000
800.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CVAC
# of Institutions
99Shares Held
14.4MCall Options Held
241KPut Options Held
419K-
Israel Englander Millennium Management LLC | New York, Ny2.87MShares$9.88 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2.42MShares$8.33 Million0.02% of portfolio
-
Black Rock Inc. New York, NY2.25MShares$7.75 Million0.0% of portfolio
-
Bill & Melinda Gates Foundation Seattle, WA1.6MShares$5.5 Million9.09% of portfolio
-
Camber Capital Management LP Boston, MA550KShares$1.89 Million0.05% of portfolio
About CureVac N.V.
- Ticker CVAC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,467,008
- Market Cap $645M
- Description
- CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...